Charles Gillies O’Bryan Tear, Director at Clarity Pharmaceuticals Ltd., holds 120.00K shares in Clarity Pharmaceuticals Ltd. (Ticker: AU:CU6). Most recently, Charles Gillies O’Bryan Tear Bought AU$120,000 shares of Clarity Pharmaceuticals Ltd. on Jun 23, 2022 for an estimated value of 53.40K.